Stock data

愛派司 (6918)

愛派司 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$79.52M, up 13.4% from a year earlier. EPS over the last four quarters totals NT$5.39.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 愛派司 in Insightr